Provost C - Search Results

1

Preclinical Evaluation of ⁶⁸Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis.

Prignon A, Provost C, Alshoukr F, Wendum D, Couvelard A, Barbet J, Forgez P, Talbot JN, Gruaz-Guyon A. Prignon A, et al. Among authors: provost c. Mol Pharm. 2019 Jun 3;16(6):2776-2784. doi: 10.1021/acs.molpharmaceut.9b00283. Epub 2019 May 3. Mol Pharm. 2019. PMID: 31013092

2

68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.

Provost C, Prignon A, Cazes A, Combaret V, Delattre O, Janoueix-Lerosey I, Montravers F, Talbot JN. Provost C, et al. Anticancer Res. 2016 Sep;36(9):4459-66. doi: 10.21873/anticanres.10990. Anticancer Res. 2016. PMID: 27630282

3

Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies.

Malinge J, Géraudie B, Savel P, Nataf V, Prignon A, Provost C, Zhang Y, Ou P, Kerrou K, Talbot JN, Siaugue JM, Sollogoub M, Ménager C. Malinge J, et al. Among authors: provost c. Mol Pharm. 2017 Feb 6;14(2):406-414. doi: 10.1021/acs.molpharmaceut.6b00794. Epub 2017 Jan 12. Mol Pharm. 2017. PMID: 28029258

4

[⁶⁸Ga]RGD Versus [¹⁸F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide.

Provost C, Rozenblum-Beddok L, Nataf V, Merabtene F, Prignon A, Talbot JN. Provost C, et al. Mol Imaging Biol. 2019 Apr;21(2):297-305. doi: 10.1007/s11307-018-1224-9. Mol Imaging Biol. 2019. PMID: 29948641

5

A comparative study of peptide-based imaging agents [⁶⁸Ga]Ga-PSMA-11, [⁶⁸Ga]Ga-AMBA, [⁶⁸Ga]Ga-NODAGA-RGD and [⁶⁸Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models.

Zhang-Yin J, Provost C, Cancel-Tassin G, Rusu T, Penent M, Radulescu C, Comperat E, Cussenot O, Montravers F, Renard-Penna R, Talbot JN, Prignon A. Zhang-Yin J, et al. Among authors: provost c. Nucl Med Biol. 2020 May-Jun;84-85:88-95. doi: 10.1016/j.nucmedbio.2020.03.005. Epub 2020 Mar 30. Nucl Med Biol. 2020. PMID: 32251995 Free article.

6

(68)Ga-AMBA and (18)F-FDG for preclinical PET imaging of breast cancer: effect of tamoxifen treatment on tracer uptake by tumor.

Prignon A, Nataf V, Provost C, Cagnolini A, Montravers F, Gruaz-Guyon A, Lantry LE, Talbot JN, Nunn AD. Prignon A, et al. Among authors: provost c. Nucl Med Biol. 2015 Feb;42(2):92-8. doi: 10.1016/j.nucmedbio.2014.10.003. Epub 2014 Oct 13. Nucl Med Biol. 2015. PMID: 25459112

7

Comparison and evaluation of two RGD peptides labelled with ⁶⁸Ga or ¹⁸F for PET imaging of angiogenesis in animal models of human glioblastoma or lung carcinoma.

Provost C, Prignon A, Rozenblum-Beddok L, Bruyer Q, Dumont S, Merabtene F, Nataf V, Bouteiller C, Talbot JN. Provost C, et al. Oncotarget. 2018 Apr 10;9(27):19307-19316. doi: 10.18632/oncotarget.25028. eCollection 2018 Apr 10. Oncotarget. 2018. PMID: 29721204 Free PMC article.

8

Apoptosis induction by combination of drugs or a conjugated molecule associating non-steroidal anti-inflammatory and nitric oxide donor effects in medullary thyroid cancer models: implication of the tumor suppressor p73.

Ragot T, Provost C, Prignon A, Cohen R, Lepoivre M, Lausson S. Ragot T, et al. Among authors: provost c. Thyroid Res. 2015 Aug 14;8:13. doi: 10.1186/s13044-015-0025-3. eCollection 2015. Thyroid Res. 2015. PMID: 26273323 Free PMC article.

9

Cilostazol Mediates Immune Responses and Affects Angiogenesis During the Acute Phase of Hind Limb Ischemia in a Mouse Model.

Paronis E, Katsimpoulas M, Kadoglou NPE, Provost C, Stasinopoulou M, Spyropoulos C, Poulaki E, Prignon A, Kakisis I, Kostomitsopoulos NG, Bouziotis P, Kostopoulos IV, Tsitsilonis O, Lazaris A. Paronis E, et al. Among authors: provost c. J Cardiovasc Pharmacol Ther. 2020 May;25(3):273-285. doi: 10.1177/1074248419897852. Epub 2020 Jan 7. J Cardiovasc Pharmacol Ther. 2020. PMID: 31906705

10

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.

Cazes A, Lopez-Delisle L, Tsarovina K, Pierre-Eugène C, De Preter K, Peuchmaur M, Nicolas A, Provost C, Louis-Brennetot C, Daveau R, Kumps C, Cascone I, Schleiermacher G, Prignon A, Speleman F, Rohrer H, Delattre O, Janoueix-Lerosey I. Cazes A, et al. Among authors: provost c. Oncotarget. 2014 May 15;5(9):2688-702. doi: 10.18632/oncotarget.1883. Oncotarget. 2014. PMID: 24811913 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page